mRNA technology can be useful in developing HIV vaccines — expert
Disclaimer: TASS is Russian government propaganda, and not a reliable news source.
“You can immunize a patient often, a lot and for a long time, even with weak T-cell immunogens. This is where this technology can make a difference,” deputy director of the Gamaleya Research Institute of Epidemiology and Microbiology Denis Logunov said